Nifty
Sensex
:
:
17767.35
60605.79
-86.70 (-0.49%)
-236.09 (-0.39%)

Pharmaceuticals & Drugs - API

Rating :
56/99

BSE: 532482 | NSE: GRANULES

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,065.23
  • 13.87
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,748.53
  • 0.51%
  • 2.59

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.02%
  • 3.75%
  • 20.74%
  • FII
  • DII
  • Others
  • 23.66%
  • 4.75%
  • 5.08%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.29
  • 17.45
  • 13.15

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.85
  • 20.98
  • 6.56

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 28.91
  • 28.77
  • 10.02

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.63
  • 15.86
  • 16.59

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.30
  • 2.82
  • 3.47

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.77
  • 10.44
  • 11.03

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Net Sales
1,146.13
996.77
14.98%
1,150.73
888.33
29.54%
1,019.56
849.85
19.97%
1,029.97
799.31
28.86%
Expenses
914.83
823.04
11.15%
907.83
737.15
23.15%
808.05
648.42
24.62%
837.27
597.31
40.17%
EBITDA
231.29
173.73
33.13%
242.91
151.18
60.68%
211.50
201.43
5.00%
192.70
202.01
-4.61%
EBIDTM
20.18%
17.43%
21.11%
17.02%
20.74%
23.70%
18.71%
25.27%
Other Income
0.95
4.87
-80.49%
4.79
4.35
10.11%
4.67
7.62
-38.71%
3.96
3.28
20.73%
Interest
16.97
4.59
269.72%
13.22
5.46
142.12%
6.94
6.79
2.21%
6.36
6.82
-6.74%
Depreciation
48.36
39.23
23.27%
44.06
39.84
10.59%
43.36
39.38
10.11%
40.18
44.48
-9.67%
PBT
166.90
134.78
23.83%
190.41
110.23
72.74%
165.87
162.87
1.84%
150.12
153.99
-2.51%
Tax
42.57
33.90
25.58%
45.32
29.55
53.37%
38.30
42.67
-10.24%
39.12
26.42
48.07%
PAT
124.33
100.88
23.25%
145.09
80.68
79.83%
127.57
120.20
6.13%
111.00
127.57
-12.99%
PATM
10.85%
10.12%
12.61%
9.08%
12.51%
14.14%
10.78%
15.96%
EPS
5.14
4.07
26.29%
5.84
3.26
79.14%
5.14
4.85
5.98%
4.48
5.15
-13.01%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
4,346.39
3,764.92
3,237.54
2,598.65
2,279.20
1,684.62
1,410.57
1,357.18
1,292.92
1,095.86
764.37
Net Sales Growth
22.98%
16.29%
24.59%
14.02%
35.29%
19.43%
3.93%
4.97%
17.98%
43.37%
 
Cost Of Goods Sold
2,209.86
1,883.64
1,391.28
1,280.93
1,255.56
896.32
679.63
725.03
746.95
645.25
466.92
Gross Profit
2,136.53
1,881.28
1,846.27
1,317.72
1,023.64
788.30
730.93
632.15
545.97
450.61
297.45
GP Margin
49.16%
49.97%
57.03%
50.71%
44.91%
46.79%
51.82%
46.58%
42.23%
41.12%
38.91%
Total Expenditure
3,467.98
3,043.30
2,382.31
2,073.33
1,895.16
1,406.20
1,111.73
1,081.29
1,084.31
937.57
679.35
Power & Fuel Cost
-
74.66
68.85
59.74
57.67
48.22
38.67
34.97
45.73
36.70
37.71
% Of Sales
-
1.98%
2.13%
2.30%
2.53%
2.86%
2.74%
2.58%
3.54%
3.35%
4.93%
Employee Cost
-
366.44
324.29
259.04
209.82
165.21
140.19
117.57
106.96
85.84
59.71
% Of Sales
-
9.73%
10.02%
9.97%
9.21%
9.81%
9.94%
8.66%
8.27%
7.83%
7.81%
Manufacturing Exp.
-
298.74
228.39
177.94
157.62
120.84
88.60
66.97
50.89
38.68
24.34
% Of Sales
-
7.93%
7.05%
6.85%
6.92%
7.17%
6.28%
4.93%
3.94%
3.53%
3.18%
General & Admin Exp.
-
134.41
172.28
125.63
99.96
83.05
67.65
60.38
59.84
44.42
26.96
% Of Sales
-
3.57%
5.32%
4.83%
4.39%
4.93%
4.80%
4.45%
4.63%
4.05%
3.53%
Selling & Distn. Exp.
-
247.45
159.80
112.17
91.84
83.08
81.37
67.75
71.70
85.04
61.70
% Of Sales
-
6.57%
4.94%
4.32%
4.03%
4.93%
5.77%
4.99%
5.55%
7.76%
8.07%
Miscellaneous Exp.
-
37.96
37.42
57.88
22.69
9.49
15.61
8.62
2.24
1.64
61.70
% Of Sales
-
1.01%
1.16%
2.23%
1.00%
0.56%
1.11%
0.64%
0.17%
0.15%
0.26%
EBITDA
878.40
721.62
855.23
525.32
384.04
278.42
298.84
275.89
208.61
158.29
85.02
EBITDA Margin
20.21%
19.17%
26.42%
20.22%
16.85%
16.53%
21.19%
20.33%
16.13%
14.44%
11.12%
Other Income
14.37
18.22
26.88
36.56
26.68
10.84
9.93
5.62
4.34
4.31
2.06
Interest
43.49
23.21
26.28
27.02
28.46
33.06
32.26
37.07
32.35
20.43
17.67
Depreciation
175.96
158.63
151.46
136.95
105.48
76.20
71.51
58.40
52.65
29.81
23.08
PBT
673.30
558.00
704.36
397.90
276.78
180.00
204.99
186.03
127.96
112.36
46.32
Tax
165.31
145.24
154.91
115.73
89.11
63.40
65.20
61.15
37.05
37.13
13.76
Tax Rate
24.55%
26.03%
21.99%
27.19%
32.20%
35.22%
31.81%
32.87%
28.95%
33.05%
29.71%
PAT
507.99
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
75.23
32.57
PAT before Minority Interest
507.99
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
75.23
32.57
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.69%
10.96%
16.97%
11.93%
8.23%
6.92%
9.91%
9.20%
7.03%
6.86%
4.26%
PAT Growth
18.32%
-24.88%
77.30%
65.14%
60.95%
-16.59%
11.93%
37.38%
20.84%
130.98%
 
EPS
20.99
17.06
22.70
12.81
7.75
4.82
5.78
5.16
3.76
3.11
1.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
2,586.53
2,173.27
1,843.72
1,529.47
1,304.18
903.60
661.60
431.16
355.96
274.85
Share Capital
24.80
24.77
25.42
25.42
25.38
22.87
21.67
20.43
20.28
20.13
Total Reserves
2,545.01
2,126.23
1,800.02
1,493.09
1,273.38
878.28
611.13
410.74
335.43
254.41
Non-Current Liabilities
282.83
366.30
485.98
552.63
488.19
187.99
246.62
356.52
343.51
202.00
Secured Loans
233.70
333.81
414.83
478.78
433.13
123.90
183.66
302.59
295.86
174.85
Unsecured Loans
0.00
0.00
6.69
0.00
0.00
0.34
0.55
0.62
13.38
0.65
Long Term Provisions
28.31
24.84
21.50
12.58
7.70
7.25
5.58
4.03
3.97
2.04
Current Liabilities
1,641.60
1,173.10
893.40
896.48
877.91
787.13
654.75
415.03
292.54
205.78
Trade Payables
638.61
541.05
356.88
323.48
274.35
215.98
181.10
187.63
135.54
91.84
Other Current Liabilities
200.85
194.25
153.16
113.60
69.84
93.43
79.21
88.98
47.78
23.77
Short Term Borrowings
765.58
409.27
371.69
454.21
525.10
473.83
392.85
124.97
100.91
85.46
Short Term Provisions
36.56
28.53
11.66
5.20
8.62
3.90
1.58
13.45
8.30
4.71
Total Liabilities
4,511.52
3,712.67
3,223.10
2,978.58
2,670.28
1,878.72
1,562.97
1,202.71
992.01
682.63
Net Block
1,541.17
1,332.00
1,203.97
944.25
776.73
644.34
559.94
616.55
482.47
263.46
Gross Block
2,461.76
2,145.15
1,875.23
1,472.94
1,199.63
983.66
822.98
843.76
653.90
387.41
Accumulated Depreciation
920.59
813.15
671.26
528.69
422.90
339.32
263.05
227.21
171.43
123.95
Non Current Assets
2,006.54
1,715.68
1,594.41
1,696.34
1,483.71
1,050.55
744.97
699.69
611.55
388.87
Capital Work in Progress
356.23
239.08
294.20
495.95
514.52
267.43
76.56
62.03
124.56
108.80
Non Current Investment
19.67
18.99
19.34
210.42
156.56
108.23
70.11
0.19
0.19
0.19
Long Term Loans & Adv.
89.47
125.61
76.89
45.72
35.91
30.56
38.37
20.76
4.33
16.42
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.15
0.00
0.00
Current Assets
2,504.98
1,997.00
1,628.70
1,282.24
1,186.57
828.16
818.00
500.36
376.92
288.88
Current Investments
0.00
0.00
109.85
0.00
0.00
0.00
0.00
0.00
0.00
9.46
Inventories
978.55
782.18
438.43
384.21
279.95
269.18
253.72
224.52
174.16
136.48
Sundry Debtors
924.95
765.42
662.04
673.54
628.25
417.70
375.35
136.91
110.91
71.02
Cash & Bank
409.46
271.04
283.94
89.04
115.64
49.80
130.29
65.31
41.75
41.71
Other Current Assets
192.02
50.74
42.60
36.99
162.73
91.49
58.65
73.63
50.10
30.21
Short Term Loans & Adv.
130.35
127.61
91.83
98.46
114.09
51.66
48.68
2.05
28.76
16.93
Net Current Assets
863.38
823.90
735.30
385.76
308.65
41.03
163.25
85.33
84.38
83.09
Total Assets
4,511.52
3,712.68
3,223.11
2,978.58
2,670.28
1,878.71
1,562.97
1,202.72
992.01
682.64

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
332.05
432.48
476.19
262.24
-0.65
188.24
151.43
150.28
107.95
91.18
PBT
558.00
704.36
425.64
276.78
180.00
204.99
186.03
127.96
112.36
46.32
Adjustment
176.29
194.43
156.88
149.85
107.45
95.14
92.63
85.37
50.39
41.46
Changes in Working Capital
-257.19
-274.95
12.75
-75.94
-230.03
-52.37
-79.70
-31.34
-31.03
14.60
Cash after chg. in Working capital
477.10
623.84
595.27
350.69
57.42
247.77
198.97
182.00
131.73
102.39
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-145.05
-191.37
-119.08
-88.45
-58.07
-59.53
-47.54
-31.72
-23.78
-11.20
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-380.11
-277.13
-160.63
-269.82
-462.31
-326.09
-161.65
-145.55
-254.63
-127.79
Net Fixed Assets
-302.61
-204.42
-124.57
-176.36
-282.01
-249.86
-75.62
-231.53
-64.60
-89.18
Net Investments
-5.00
-36.29
-48.78
-431.34
-0.01
13.84
-16.48
72.98
-94.69
-17.96
Others
-72.50
-36.42
12.72
337.88
-180.29
-90.07
-69.55
13.00
-95.34
-20.65
Cash from Financing Activity
190.00
-299.31
-212.85
-17.43
528.62
55.87
85.67
18.83
146.72
46.33
Net Cash Inflow / Outflow
141.94
-143.97
102.70
-25.01
65.66
-81.98
75.44
23.56
0.04
9.72
Opening Cash & Equivalents
41.84
185.93
83.02
108.03
42.37
124.35
54.85
41.75
41.71
31.98
Closing Cash & Equivalent
184.71
41.84
185.93
83.02
108.03
42.37
130.29
65.31
41.75
41.71

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
103.62
86.85
71.80
59.73
51.17
39.40
29.20
20.98
17.36
13.40
ROA
10.04%
15.84%
9.99%
6.64%
5.13%
8.12%
9.03%
8.31%
8.98%
5.19%
ROE
17.49%
27.64%
18.54%
13.32%
10.60%
18.23%
23.53%
23.29%
24.20%
12.67%
ROCE
17.37%
25.42%
17.22%
12.71%
11.09%
16.57%
20.16%
18.75%
19.90%
12.95%
Fixed Asset Turnover
2.26
1.97
1.75
1.78
1.55
1.59
1.66
1.77
2.14
2.11
Receivable days
59.15
65.94
83.34
100.03
112.83
100.84
67.60
33.47
29.73
38.66
Inventory Days
61.61
56.39
51.34
51.03
59.23
66.49
63.11
54.79
50.77
57.37
Payable days
114.29
117.79
58.20
54.96
62.37
64.87
59.99
53.57
43.67
44.19
Cash Conversion Cycle
6.46
4.54
76.48
96.10
109.70
102.46
70.72
34.69
36.83
51.84
Total Debt/Equity
0.43
0.39
0.49
0.65
0.75
0.73
1.01
1.14
1.25
1.00
Interest Cover
25.04
27.80
16.75
10.72
6.44
7.36
6.02
4.96
6.50
3.62

News Update:


  • Granules India’s arm receives ANDA approval for Amphetamine Mixed Salts ER Capsules
    24th Jan 2023, 09:39 AM

    This product will be manufactured at Granules manufacturing facility in Chantilly, Virginia and is expected to be launched shortly

    Read More
  • USFDA completes Pre-Approval inspection at Granules India’s Hyderabad facility
    16th Jan 2023, 09:42 AM

    Gagillapur facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates

    Read More
  • Granules India enters into strategic partnership with Greenko ZeroC
    3rd Jan 2023, 09:14 AM

    The facility spread across 100 acres, will be commissioned in a phase wise manner

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.